N@N

Jason Cassorla Maintained (THC) at Strong Buy with Decreased Target to $76 on, Oct 25th, 2022

Jason Cassorla of Citigroup, Maintained "Tenet Healthcare Corporation" (THC) at Strong Buy with Decreased Target from $99 to $76 on, Oct 25th, 2022.

Jason has made no other calls on THC in the last 4 months.

There are 10 other peers that have a rating on THC. Out of the 10 peers that are also analyzing THC, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $45 on, Monday, October 24th, 2022

These are the ratings of the 9 analyists that currently disagree with Jason

---

• Pito Chickering of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $48 on, Monday, October 24th, 2022
• Sarah James of "Barclays" Maintained at Buy with Decreased Target to $67 on, Monday, October 24th, 2022
• Stephen Baxter of "Wells Fargo" Maintained at Buy with Decreased Target to $48 on, Monday, October 24th, 2022
• Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $80 on, Tuesday, August 2nd, 2022
• Andrew Mok of "UBS" Maintained at Strong Buy with Decreased Target to $91 on, Thursday, July 28th, 2022
• John Ransom of "Raymond James" Maintained at Strong Buy with Increased Target to $135 on, Tuesday, July 26th, 2022
• David Macdonald of "Truist Securities" Maintained at Strong Buy with Increased Target to $80 on, Monday, July 25th, 2022
• Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $99 on, Monday, July 25th, 2022
• Jamie Perse of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $93 on, Tuesday, July 12th, 2022

Contributing Sources

---